PRA Health Sciences offers our services as a contractor for US Government (USG) contract-funded projects and as a commercial procurement vendor for USG grant-funded projects. Since 2012, we have partnered with 13 clients on 25 USG-funded projects to tackle public health issues, such as emerging infectious diseases, and to enhance care and treatments for USG civilian and military agencies. PRA is committed to providing consistent, transparent approaches that ensure high-quality outcomes for our USG-funded partners.
PRA Health Sciences Investor Relations
Decoding FDA Gene Therapy Guidances Part One: Chemistry, Manufacturing, and Control
In Part One of our Decoding FDA Gene Therapy Guidances series, we discuss the significance of several new FDA guidances regarding human gene therapy…
Multi-stakeholder Collaboration Achieves Rapid Study Start-up for an Advanced Therapeutic
PRA worked with an emerging biotech firm to implement a first-in-human clinical trial using a live biotherapeutic product for a rare disease…